Published in Virology on June 01, 1979
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol (2000) 3.74
Pathogenicity of influenza virus. Microbiol Rev (1980) 2.80
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol (1993) 2.40
Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol (1990) 1.84
Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A (1982) 1.71
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol (1999) 1.57
The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol (1989) 1.52
Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model. J Virol (1991) 1.36
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers. Infect Immun (1981) 1.27
Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis. J Virol (1986) 1.10
Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS One (2010) 1.05
The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology (2009) 1.01
New aspects of influenza viruses. Clin Microbiol Rev (1992) 0.97
Multiple genome segments determine virulence of bluetongue virus serotype 8. J Virol (2015) 0.83
Neurovirulence mutant of vesicular stomatitis virus with an altered target cell tropism in vivo. Infect Immun (1980) 0.81
Residue 41 of the Eurasian avian-like swine influenza a virus matrix protein modulates virion filament length and efficiency of contact transmission. J Virol (2014) 0.79
Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines. Bull World Health Organ (1984) 0.75
On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology (1985) 5.65
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell (1987) 4.34
Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol (2000) 3.35
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J Infect Dis (1979) 3.15
Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus. Nature (1989) 3.10
European swine virus as a possible source for the next influenza pandemic? Virology (1995) 3.07
Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds. Virology (1983) 3.02
Functional significance of sialidose during influenza virus multiplication. Virology (1966) 2.94
The molecular biology of influenza virus pathogenicity. Adv Virus Res (1988) 2.90
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science (1985) 2.57
Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology (1978) 2.51
Evolution of pig influenza viruses. Virology (1991) 2.40
Correlation between RNA fragments of fowl plague virus and their corresponding gene functions. Virology (1976) 2.36
Replication of Borna disease virus in cell cultures. Med Microbiol Immunol (1980) 2.24
Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus. J Virol (1978) 2.16
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol (1972) 2.12
Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science (1983) 2.10
Phylogenetic analysis of nucleoproteins suggests that human influenza A viruses emerged from a 19th-century avian ancestor. Mol Biol Evol (1990) 2.07
Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet (1991) 2.02
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Virology (1970) 1.95
Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. J Gen Virol (1997) 1.94
Molecular basis of infectivity and pathogenicity of myxovirus. Brief review. Arch Virol (1979) 1.89
Generation of seal influenza virus variants pathogenic for chickens, because of hemagglutinin cleavage site changes. J Virol (1990) 1.81
Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81
Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine. J Virol (1999) 1.81
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
Effect of 2-deoxy-D-glucose on the multiplication of Semliki Forest virus and the reversal of the block by mannose. Virology (1973) 1.78
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood (1991) 1.74
Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73
Two subtypes of nucleoproteins (NP) of influenza A viruses. Virology (1989) 1.73
Persistent infection of human fibroblasts by hepatitis A virus. J Gen Virol (1984) 1.72
Host range mutants of an influenza A virus. Arch Virol (1978) 1.69
The 24K protein of Borna disease virus. J Gen Virol (1992) 1.69
Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis (1983) 1.66
Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol (1991) 1.65
A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases. Science (1990) 1.63
Detection of an unstable RNA in chick fibroblasts after reduction of the UTP pool by glucosamine. Eur J Biochem (1971) 1.62
Specific inhibition of influenza replication by alpha-amanitin. Nature (1970) 1.61
Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus. Virology (1994) 1.58
Borna disease virus: a mystery as an emerging zoonotic pathogen. Vet J (2001) 1.57
Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J Infect Dis (1983) 1.56
Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine (1985) 1.55
Phylogenetic relationship of the nonstructural (NS) genes of influenza A viruses. Virology (1991) 1.55
Inhibition of influenza RNA synthesis by virazole (ribavirin). Arch Virol (1976) 1.54
Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J (1992) 1.54
Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains. J Gen Virol (1979) 1.54
An avian influenza A virus killing a mammalian species--the mink. Brief report. Arch Virol (1985) 1.53
Purification and properties of an intranuclear virus-specific antigen from tissue infected with Borna disease virus. J Gen Virol (1986) 1.51
Nucleoside-diphosphate derivatives of 2-deoxy-D-glucose in animal cells. Eur J Biochem (1974) 1.50
Replication of Borna disease virus in rats: age-dependent differences in tissue distribution. Med Microbiol Immunol (1984) 1.48
Cotranslational and posttranslational processing of viral glycoproteins. Curr Top Microbiol Immunol (1980) 1.47
Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses. J Gen Virol (1989) 1.47
Borna disease virus. A possible etiologic factor in human affective disorders? Arch Gen Psychiatry (1985) 1.46
Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol (1989) 1.45
The genome of the influenza virus. Curr Top Microbiol Immunol (1978) 1.44
Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J Virol (1990) 1.43
Detection of hepatitis A virus in sewage sludge by antigen capture polymerase chain reaction. Appl Environ Microbiol (1993) 1.42
Genetic relatedness of the gene which codes for the nonstructural (NS) protein of different influenza A strains. Virology (1980) 1.41
Amantadine-resistant and -sensitive influenza A strains and recombinants. J Gen Virol (1979) 1.41
Immunologic and genetic relationship between herpes simplex virus and bovine herpes mammillitis virus. Intervirology (1974) 1.41
Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology (1987) 1.40
Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones. J Immunol (1985) 1.40
Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J Med Virol (1977) 1.39
Borna disease, a progressive meningoencephalomyelitis as a model for CD4+ T cell-mediated immunopathology in the brain. J Exp Med (1989) 1.39
Hepatitis A-virus in cell culture: I. propagation of different hepatitis A-virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med Microbiol Immunol (1980) 1.39
Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol (1995) 1.38
Abortive infection of Vero cells by an influenza A virus (FPV). Virology (1995) 1.37
Genomic organization of the structural proteins of borna disease virus revealed by a cDNA clone encoding the 38-kDa protein. Virology (1993) 1.37
Host range recombinants of fowl plague (influenza A) virus. Virology (1978) 1.37
Antigenic relationship and further characterization of two major Borna disease virus-specific proteins. J Gen Virol (1992) 1.36
The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol (1979) 1.35
Studies on the uptake of nucleic acid precursors into cells in tissue culture. Biochim Biophys Acta (1968) 1.35